Investigating the changes of the components of the Krebs cycle in patients with type 2 diabetes treated with squalene

Authors

  • Hossein Mirmiranpour Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  • Mohammad Reza Ashoori Department of Laboratory Sciences, School of Allied Medical Sciences, Zanjan University of Medical Sciences, Zanjan, Iran
  • Afsaneh Seyed Mikaeili Department of Molecular and Cellular Sciences, Faculty of Advanced Sciences and Technology, Islamic Azad University, Pharmaceutical Sciences Branch, Tehran, Iran
  • Benjamin Chen University of California, Merced, CA, USA
  • Danik Martirosyan Functional Food Center, Dallas, TX, USA

DOI:

https://doi.org/10.31989/bchd.v6i2.1059

Abstract

Background: Type 2 diabetes mellitus is a chronic disease that impairs the body’s ability to regulate glucose. Recent studies have shown that squalene, a bioactive compound, has shown promising potential in increasing ATP levels for diabetic patients and aged individuals.

Objective: Our main goal was to evaluate the cellular effects of different doses of squalene on the intermediates and enzymes of Krebs cycle, in order to determine if squalene increases ATP production among groups of people with type 2 diabetes. The intermediates and enzymes that are being studied are acetyl coenzyme (A-CoA), alpha ketoglutarate dehydrogenase (AKGDH), calcium ion (Ca2+), citrate synthase (CS), isocitrate dehydrogenase, oxaloacetate, and pyruvate dehydrogenase complex component (PDH).

Methods: In this study, 30 healthy volunteers were selected as the healthy control group (group 1) and 120 volunteers with type 2 diabetes mellitus were selected. Subjects with diabetes were randomly divided into 4 groups. Group 2 was untreated with squalene and groups 3, 4, and 5 were treated with 200, 400 and 600 mg of squalene, respectively for 84 days. Intermediates and enzymes of the Krebs cycle as well as calcium ion were assayed on days 1, 14, 28, 56, and 84 according to the relevant protocols in all groups.

Results: The squalene-treated diabetic groups were compared to group 2 that was not treated any squalene to determine the differences of the parameters. Throughout these 84 days, it was observed that only calcium levels increased in the diabetic patients with high statistical difference (P < 0.05). The other parameters: acetyl coenzyme, alpha ketoglutarate dehydrogenase, citrate synthase, isocitrate dehydrogenase, oxaloacetate, and pyruvate dehydrogenase did not have a significant difference (P > 0.05). 

Conclusion: Based on the findings of this study, the addition of various doses of squalene to a diabetic patient's diet increases the amount of calcium found in their metabolic process in relation to the Krebs cycle. As calcium is responsible for stimulating the Krebs Cycle, it is evident that squalene plays an important part in ATP production.


Keywords: squalene, type 2 diabetes, Krebs cycle, calcium, ATP

Downloads

Published

2023-02-22

Issue

Vol. 6 No. 2 (2023): February 2023

Section

Research Articles

License

Any manuscripts or substantial parts of it, submitted to the journal must not be under consideration by or previously published in any other journal or citable form. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights or the rights of a third party. In submitting one's article in any form, the author has assigned the FFC publishing rights and has agreed to an automatic transfer of the copyright to the publisher. This is so that the FFC may create print option journals, for example, at the FFC’s discretion. If the author wishes to distribute their works by means outside of the FFC, for example within their community, they will have to place a request. 

 

Correspondence concerning articles published in Functional Foods in Health and Disease is encouraged. While derivative works (adaptations, extensions on the current work, etc.) are allowed, distribution of the modified material is not allowed without permission from the FFC.